We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+21.79%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$584M
AUM Growth
+$67M
Cap. Flow
-$4.03M
Cap. Flow %
-0.69%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$6.21M
2
AST.WS
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
+$89.7K

Top Sells

Rank Stock Value
1
IMPR
IMPRIVATA, INC COM
IMPR
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 50.87%
2 Consumer Staples 40.17%
3 Miscellaneous 8.96%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$87.5B
$235M 40.17%
19,189,632
– –
STAA icon
2
STAAR Surgical
STAA
$1.14B
$102M 17.46%
10,855,179
– –
LCTX icon
3
Lineage Cell Therapeutics
LCTX
$263M
$97.1M 16.61%
28,457,308
– –
IWM icon
4
iShares Russell 2000 ETF
IWM
$76.1B
$52.2M 8.93%
420,000
– –
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$46.7M 7.99%
916,975
– –
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$22.5M 3.85%
322,411
– –
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$15.7M 2.68%
3,699,848
– –
IMDX
8
Insight Molecular Diagnostics
IMDX
$118M
$13.3M 2.27%
131,584
+76,923
+141% +$6.21M
AST.WS
9
DELISTED
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
$171K 0.03%
+328,205
New +$89.7K
IMPR
10
DELISTED
IMPRIVATA, INC COM
IMPR
– –
-737,911
Closed -$10.3M

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Broadwood Capital held 10 positions worth $584M, up 13% from $517M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q3 2016 filing shows 1 new, 1 increased and 1 closed positions. Its largest new stake was Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017): 328,205 shares worth $171K. The largest sale was IMPRIVATA, INC COM, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 39% a quarter earlier, followed by Consumer Staples and Miscellaneous.

  • Broadwood Capital's largest Q3 2016 buy was Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017): 328,205 shares worth $171K.
  • Broadwood Capital added most to Insight Molecular Diagnostics in Q3 2016, an estimated $6.21M increase.
  • Broadwood Capital fully exited IMPRIVATA, INC COM in Q3 2016, selling an estimated $10.3M.
  • Broadwood Capital's ten largest holdings make up 100% of its $584M portfolio in Q3 2016.
  • Broadwood Capital opened 1 new position and closed 1 in Q3 2016.
  • Broadwood Capital's portfolio value rose 13% quarter-over-quarter to $584M.

Based on Broadwood Capital's 13F filing for Q3 2016, filed 14 Nov 2016.